A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

NCT05438602 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Nirmatrelvir
DRUG: Ritonavir
DRUG: Placebo for nirmatrelvir
DRUG: Placebo for ritonavir

Sponsor

Pfizer